"Designing Growth Strategies is in our DNA"

Nicotine Replacement Therapy (NRT) Market Size, Share & COVID-19 Impact Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI103362

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global nicotine replacement therapy (NRT) market size was valued at USD 2.55 billion in 2019 and is projected to reach USD 3.54 billion by 2027, exhibiting a CAGR of 4.2% during the forecast period.

COVID-19 Cover

This report covers COVID-19 impact analysis on Nicotine Replacement Therapy (NRT) Market

Request Sample

According to the World Health Organization (WHO), tobacco is responsible for the death of more than 8 million people every year and is the second leading cause of global cancer deaths. This is an underlying burden on the healthcare industry to save millions of people. Therefore, to reduce tobacco consumption and help smokers get rid of the urge to smoke, nicotine replacement therapy was approved by the U.S FDA by introducing products such as nicotine gums, patches, lozenges, and others. Since then, pharmaceutical giants GlaxoSmithKline and Johnson & Johnson are actively supplying products to the world.


Nicotine products have been effective in helping people quit smoking and thus are widely used by strugglers who are trying to quit smoking. Moreover, the launch of awareness campaigns worldwide about the health benefits of quitting smoking has leveraged the market potential by influencing more population towards the prohibition of smoking.


Anti-Smoking Awareness Programs Amid COVID-19 to Aid Growth


COVID-19 is a respiratory disease prone to affect millions of people with low immunity levels. For preventive measures, health organizations such as WHO, CDC, and others have advised smokers to quit smoking. As smoking damages the lungs, it makes the person more vulnerable to the COVID-19 disease. This was proactively supported by Cipla Health Limited by initiating a campaign in April 2020 known as ‘21 Days to Quit Smoking Challenge’ by introducing them to the Nicotex gum NRT product.


In May 2020, at the World Health Assembly, many countries showed efforts in banning the sales of tobacco products as it affects the lungs making people vulnerable to the infection. This has eventually led to the increased awareness amongst the population to the nicotine replacement therapy market and its adoption. Therefore, over the coming year marking modest growth rate, the global market will witness considerable growth during the forecast period.


LATEST TRENDS


Request a Free sample to learn more about this report.


Introduction of Smartphone Apps, and Behavioral Techniques to Drive the Market Growth


To help the smokers in smoking cessation, many companies and doctors are focused on the introduction of novel ways to tackle the problem. The latest trend in smoking cessation is the introduction of smartphone apps such as Cessation Nation, MyQuit Coach, QuitNow, SmokeFree, and many others. These apps are helping smokers in tracking their daily habits, providing tips on non-smoking, and connecting them with communities that help in quitting smoking. Moreover, many researchers are investigating ways to look into the smoker’s mind and help them quit smoking. According to the study by Westmass, engaging the population in activities that are ‘self-expanding’ can help them get rid of nicotine cravings. Such progressive trends in the nicotine industry are likely to increase the adoption rate of NRT products during the forecast period.


DRIVING FACTORS


Increasing Government/International Organizations Efforts to Promote Anti-Smoking Activities to Fuel Demand


According to the Union of International Cancer Control (UICC), tobacco consumption is anticipated to kill a billion people in the 21st century. Tobacco consumption is the second leading cause of 22% of global cancer deaths. Such a fearful situation has helped various organizations around the world to come up with awareness campaigns and various initiatives. For instance, 31st May every year is marked as World No Tobacco Day globally, to raise awareness among the population about the health hazards of tobacco consumption and the adoption of NRT products. Additionally, in July 2017 according to WHO, more than 2 million people enrolled in the Quit Smoking program of India in a year by adopting NRT products. Owing to initiatives by government and other organizations, growing population towards anti-smoking is likely to grab them to higher adoption of NRT products thus increasing its demand and sales.


Launch of Innovative Products to Propel Market Growth


Owing to increased burden in minimizing the number of smokers, pharmaceutical giants are focused on introduction of innovative and effective nicotine replacement therapy products. This is likely to boost the global market value by propelling higher sales and adoption. For instance, in May 2017, Glenmark Pharmaceuticals announced the launch of Kwitz, a product that helps smokers in smoking cessation within three months. Additionally, in May 2017, Cipla Health Limited launched Nicotex Nicotine Patch, as a Nicotine replacement therapy product. The transdermal patch helps in reducing the urge to smoke in smokers. Therefore, constant product launches by major companies are likely to contribute to the generation of higher market revenue during the forecast period.


RESTRAINING FACTORS


Myths Surrounding NRT to Limit Product Adoption


Inspite of the tremendous awareness about the harmful effects of smoking through awareness campaigns, television ads, flyers, and others, the rate of people willing to quit smoking is lower. According to the data from Centers for Disease Control & Prevention (CDC) in 2018, although 55.1% of the adult made a quit attempt only 7.5% of them successfully discontinued smoking. Moreover, the launch of effective NRT products and awareness among the population still leads to the lesser adoption of products. As per a research study conducted by World Health Organization (WHO), there are misconceptions in the population about the NRT products. These include that the products cannot reduce smoking habit, are not effective, have side-effects, and are expensive. Therefore, due to the circulating myths about the products, it has lowered the adoption rate eventually leading to lower sales.


SEGMENTATION


By Type Analysis


To know how our report can help streamline your business, Speak to Analyst


Gums to Grow at Faster Pace


Based on product type, the market for nicotine replacement therapy is classified into gums, patches, lozenges, inhalers, and others. Gums dominated the product type segment in 2019 accounting for the highest market share. The factor attributable to the dominance is higher sales of nicotine gums. Nicotine gums are available over-the-counter without a prescription and help reduce nicotine cravings. Therefore, as the gums are easily available they are highly preferred subsequently increasing the sales of the product. For example, in May 2018, Cipla’s Nicotex announced the partnership with BEST (Brihanmumbai Electricity Supply and Transport Undertaking) on the World’s No Tobacco Day. The partnership has enabled Nicotex to train a large number of doctors, nurses, and pharmacies to spread awareness on the right dosage of NRT products to help quit tobacco by the BEST employees and passengers.


 Nicotine patches hold the second position in the market owing to its effectiveness in reducing the urge to smoke. Manufacturers are highly focused on introducing nicotine patches which are likely to boost the sales of the NRT products. Moreover, NRT products such as lozenges, inhalers, and sprays are useful in prohibiting smoking. Therefore, rising awareness among the population is anticipated to increase the sales of the product during the forecast period.


By Distribution Channel Analysis


Retail Pharmacies to Register a Higher CAGR


In terms of the distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.


The hospital pharmacy is expected to have a dominant share in the market during the forecast period. The dominance is attributable to an increase in hospital stays of patients suffering from chronic diseases such as cancer, lung cancer, respiratory disease, strokes, etc., due to excessive smoking habits. This has led to increased sales of NRT products to spread awareness about the importance of prohibiting smoking.


During the forecast period, retail pharmacies are expected to emerge as the fastest-growing segment owing to the smokers’ preference in purchasing NRT products from the nearby retail stores. Additionally, the issuance of guidelines to the pharmacies by the government is anticipated to contribute to driving the population towards adoption of NRT products. For instance, National Institute of Health and Clinical Excellence (NHS) of England has drafted guidelines for pharmacists to help smokers quit tobacco smoking.


REGIONAL INSIGHTS


North America Nicotine Replacement Therapy Market Size, 2019 (USD Billion)

To get more information on the regional analysis of this market, Request a Free sample


Regionally, the nicotine replacement therapy market is fragmented by North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.


North America and Europe together account for the majority share of the market at about 80%. The market size in North America stood at USD 1.18 billion in 2019. The dominance of this region is attributable to the highest retail sales of NRT products in U.S and Canada. The rate of smokers that are practicing prohibition of smoking is increasing in the region, and hence the demand for NRT products such as gums, inhalers, etc., is higher. Additionally, smoking cessation rates in the U.S are higher than in other countries, which have led to the increasing sales of NRT products. According to the Center of Disease Control & Prevention (CDC) survey, approximately 68% of the U.S population has decided to quit smoking. Therefore, this is anticipated to raise the sales of the products in the coming years. Moreover, gums are dominantly used in the U.S to get rid of smoking than other products in the market.


The market in Europe holds the second position owing to the growing sales of products in European countries such as the U.K, Germany, etc. Furthermore, the government in the region is strongly focused on implementing initiatives for ‘quit smoking’. For instance, the government of the U.K is keen on spreading awareness among the population by regularly updating articles about the benefits of quitting smoking on its portal.


To know how our report can help streamline your business, Speak to Analyst


The market in the Asia Pacific is expected to exhibit healthy growth owing to the growing awareness among the population about the side effects of smoking coupled with robust government support in prohibiting tobacco consumption in the region. For instance, the Times of India published an article in March 2020 about ‘Quit Smoking’ wherein the awareness regarding NRT products was also stated. Latin America & the Middle East & Africa accounted for a comparatively lower share owing to the presence of a huge untapped market for the NRT products and lesser awareness about the importance of quitting tobacco consumption.


KEY INDUSTRY PLAYERS


The global market for nicotine replacement therapy is a conserved market by having two leading players GlaxoSmithKline and Johnson & Johnson Inc. accounting for approximately 80% of the share. GSK’s vast portfolio of NRT products such as NicoDerm CQ Patch, Nicorette Gum, Lozenges available in various dosages and flavors have contributed to the dominance. GSK’s strong distribution channel and reliable brand presence among the population have led to its higher revenue generation. J&J having products such as sprays, gums, inhalers, and the patch is also the leading player in the market.


Other players such as Pfizer, Perrigo Company plc, and Cipla have considerable shares in the global market. Launching campaigns to stop smoking and raising awareness about the adoption of NRT products by the companies is helping in increasing their sales. Therefore, leveraging the market value.


LIST OF KEY COMPANIES PROFILED:



  • GlaxoSmithKline plc (U.K, Europe)

  • Johnson & Johnson Inc (New Jersey, U.S)

  • Perrigo Company plc (Ireland, Europe)

  • Pierre Fabre SA, Laboratories (France, Europe)

  • Pfizer Inc. (New York, United States)

  • Cipla Limited (Mumbai, India)

  • British American Tobacco Plc (U.K, Europe)

  • Other Players


KEY INDUSTRY DEVELOPMENTS:



  • May 2020 – Cipla Health’s smoking cessation brand Nicotex announced the collaboration with Karnataka and Goa governments to provide nicotine replacement therapy to the frontline workers.

  • July 2019 - PL Developments expanded its NRT space by collaborating with Teva’s U.S OTC products.


REPORT COVERAGE


The nicotine replacement therapy market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the advanced market over recent years.


To gain extensive insights into the market, Request for Customization


Report Scope & Segmentation














































 ATTRIBUTE



  DETAILS



Study Period



  2016-2027



Base Year



  2019



Forecast Period



  2020-2027



Historical Period



  2016-2018



Unit



  Value (USD Billion)



Segmentation



  Type; Distribution Channel; and Geography



By Type


 




  • Gums

  • Patches

  • Lozenges

  • Inhalers

  • Others



By Distribution Channel


 




  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy



By Geography


 




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • The Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Frequently Asked Questions

Fortune Business Insights says that the global nicotine replacement therapy market size was USD 2.55 billion in 2019 and is projected to reach USD 3.54 billion by 2027.

In 2019, the North America market value stood at USD 1.18 billion.

Growing at a CAGR of 4.2%, the market will exhibit steady growth in the forecast period (2020-2027).

The gums segment is expected to be the leading segment in this market during the forecast period.

Increasing addiction of smokers coupled with growing government initiatives to make a smoke free world are the factors driving the growth of the market.

GlaxoSmithKline and Johnson & Johnson Inc are major players of the global market.

North America dominated the market share in 2019.

Rising awareness among the population about side effects of smoking in addition to the launch of innovative products is expected to drive the adoption in the global market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
Nicotine Replacement Therapy (NRT) Market Size, Share and Global Industry Trend Forecast till 2026
  • Aug, 2020
  • 2019
  • 2016-2018
  • 114

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

lpsos
Natus-Medical
chong-kun-dang
novo-nordisk
SUANFARMA

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X